Aller au contenu
Force et musclesRevue des preuves3 min read

About 1 in 5 older adults in China has sarcopenia, rising steeply after age 80

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis. · Frontiers in public health · 2024 · Article original ↗

À retenir

Pooling 45 studies with 37,571 people aged 60 or older in China, the prevalence of sarcopenia was 20.7% (95% CI 18.3 to 23.0%), reaching 45.4% at age 80 and above. The pooled studies were cross-sectional, so the listed risk factors are associations, and different diagnostic criteria gave noticeably different rates.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Sarcopenia, the loss of muscle mass and strength with age, raises the risk of falls and disability, yet national-level numbers for China were scattered. The authors wanted a pooled prevalence among people aged 60 and over, and the factors most tied to having it, to guide early detection and prevention.

Population et méthode

Systematic review and meta-analysis of prevalence studies. Seven databases (CNKI, Wanfang, VIP, PubMed, Web of Science, Embase, Cochrane Library) were searched from their start until January 31, 2024. Study quality was assessed with the Agency for Healthcare Research and Quality (AHRQ) criteria for cross-sectional studies, and analysis used Stata 18.0. In total 45 studies with 37,571 cases were included, with subgroups by sex, age, region, publication period and diagnostic criteria.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Overall prevalence of sarcopenia among older adults in China was 20.7% (95% CI 18.3 to 23.0%).
  2. 2
    Prevalence rose sharply with age: 15.7% at 60 to 69, 27.2% at 70 to 79 and 45.4% at 80 and above. It was higher in women (21.6%) than in men (19.2%), and in the south (21.7%) than in the north (19.0%).
  3. 3
    Prevalence rose from 19.2% in studies from 2014 to 2018 to 21.4% in studies from 2019 to 2024. The Asian Working Group for Sarcopenia (AWGS) 2019 criteria found more cases than AWGS 2014 (24.5% versus 19.3%).
  4. 4
    Ageing, low BMI, low leg or calf circumference, smoking, depression, osteoporosis, malnutrition and risk of malnutrition were all linked to sarcopenia.

Limites et incertitude

  1. 1
    The included studies were cross-sectional, so they cannot show whether smoking, depression or low BMI came before sarcopenia or followed it.
  2. 2
    Different diagnostic criteria (AWGS 2014 versus 2019) gave different prevalence figures, so the pooled 20.7% mixes definitions.
  3. 3
    The abstract gives no heterogeneity statistics, and subgroup differences by sex, region and period are described without confidence intervals.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

The numbers suggest that sarcopenia is common after 70 and very common after 80, so grip strength, walking speed and weight loss are worth watching in older relatives. The listed risk factors fit a general picture of poor nutrition and low muscle reserves, but the paper cannot show that fixing one will prevent sarcopenia. Diagnosis and treatment are for a clinician.

Vos données

Smart scales and wearables can log body weight, step counts and walking pace, which can flag a drift. Weigh at the same time under similar conditions and watch trends over months, since unexplained weight loss or slowing gait is more informative than one reading. Body-composition scales estimate muscle poorly compared with clinical assessments.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Understanding the epidemiological information of a certain disease is the first step in related prevention and control work. This article aims to understand the prevalence and associated risk factors of sarcopenia among the older adult (≥60 years old) in China and to provide an evidence-based basis for early identification, management, and prevention of sarcopenia patients.

Methods

We searched seven databases: CNKI, Wanfang, VIP, PubMed, Web of Science, Embase, and Cochrane Library databases from the establishment of the database until January 31, 2024. The Quality evaluation criteria of cross-sectional studies recommended by the Agency for Healthcare Research and Quality (AHRQ) were used for literature quality evaluation. Stata 18.0 software was used for statistical analysis.

Results

We finally included 45 studies, involving a total of 37,571 cases. After statistical analysis, we found that the prevalence of sarcopenia among the older adult in China was 20.7% [95% CI (18.3, 23.0%)]. The results of subgroup analysis suggest that: ① According to gender, the prevalence rate of sarcopenia in women (21.6%) is higher than that in men (19.2%); ② According to age, the prevalence rate of older adult people aged ≥80 (45.4%) was the highest, followed by 70-79 (27.2%) and 60-69 (15.7%). ③ According to region, the prevalence rate of the older adult in the south (21.7%) is higher than that in the north (19.0%); ④ According to the time of publication, the prevalence of sarcopenia among the older adult in China has increased (from 19.2% in 2014-2018 to 21.4% in 2019-2024); ⑤ According to the diagnostic criteria, the detection rate of AWGS (2019) is higher than that of AWGS (2014) (24.5% vs. 19.3%). Finally, aging, low BMI, low leg circumference, smoking, depression, osteoporosis, malnutrition and malnutrition risk are all risk factors for sarcopenia among the older adult in China.

Conclusion

The prevalence of sarcopenia in the older adult in China was higher (20.7%), which should be paid attention to by relevant health authorities. In addition, aging, low BMI, low calf circumference, smoking, depression, osteoporosis, malnutrition and malnutrition risk are risk factors for the development of sarcopenia in the older adult in China. For these high-risk populations, early identification, prevention, and intervention can be carried out to delay the occurrence and progression of sarcopenia.

Sources et attribution

The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis.

Meng S, He X, Fu X, Zhang X, Tong M, Li W, Zhang W, Shi X, Liu K.

Frontiers in public health · 2024-08-05

DOI: 10.3389/fpubh.2024.1415398 ↗PubMed · 39161853 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Synthèse de revues

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
Force et muscles →